BEACON INVESTMENT ADVISORY SERVICES, INC.
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1654599
MORRISTOWN, NJ
Position in ALNY
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$29,801
-$39,681 QoQ
Shares Held
99
-52.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#628
of 764 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BEACON INVESTMENT ADVISORY SERVICES, INC. holds $27,845,665 across 16 Biotechnology names. ALNY ranks #5 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
53,380 | $26,515,447 | |
| 2 | INCY |
Incyte Corp
|
5,608 | $635,722 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
757 | $472,019 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
14,000 | $137,480 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
99 | $29,801 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
271 | $14,780 | |
| 7 | TECH |
BIO-TECHNE Corp
|
140 | $9,891 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
1,000 | $8,370 |
All Filings in ALNY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,801 | 99 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $69,482 | 210 | Shares | Sole | 2026-04-14 | |
| 2025-09-30 | $266,760 | 585 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $420,656 | 1,290 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $455,793 | 1,688 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $875,588 | 3,721 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,210,407 | 4,401 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,126,548 | 4,636 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $749,940 | 5,018 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,044,141 | 5,455 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,260,066 | 7,115 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,929,030 | 10,156 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $2,094,746 | 10,457 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $2,528,596 | 10,640 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,137,508 | 10,679 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,590,640 | 10,906 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $1,794,883 | 10,992 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,867,584 | 11,013 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,752,345 | 9,281 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,514,661 | 8,935 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,176,536 | 8,333 | Shares | Sole | 2021-05-21 | |
| 2020-12-31 | $588,764 | 4,530 | Shares | Sole | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||